Patawut Bovonratwet, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fusion | 17 | 2022 | 1228 | 3.490 |
Why?
|
| Arthroplasty, Replacement, Knee | 17 | 2022 | 1351 | 3.170 |
Why?
|
| Arthroplasty, Replacement, Hip | 17 | 2022 | 1376 | 2.710 |
Why?
|
| Ambulatory Surgical Procedures | 8 | 2023 | 447 | 2.460 |
Why?
|
| Patient Readmission | 24 | 2023 | 3170 | 2.260 |
Why?
|
| Postoperative Complications | 39 | 2023 | 15341 | 2.050 |
Why?
|
| Enterocolitis, Pseudomembranous | 3 | 2018 | 265 | 1.570 |
Why?
|
| Diskectomy | 5 | 2022 | 204 | 1.480 |
Why?
|
| Lumbar Vertebrae | 10 | 2022 | 1808 | 1.430 |
Why?
|
| Arthroscopy | 4 | 2021 | 948 | 1.260 |
Why?
|
| Arthritis, Infectious | 4 | 2021 | 342 | 1.250 |
Why?
|
| Cervical Vertebrae | 7 | 2022 | 965 | 1.250 |
Why?
|
| Outpatients | 7 | 2022 | 1551 | 1.210 |
Why?
|
| Hip Fractures | 4 | 2020 | 966 | 1.180 |
Why?
|
| Spine | 7 | 2020 | 1092 | 1.110 |
Why?
|
| Debridement | 2 | 2019 | 494 | 1.040 |
Why?
|
| Length of Stay | 21 | 2022 | 6292 | 0.990 |
Why?
|
| Databases, Factual | 22 | 2020 | 7812 | 0.990 |
Why?
|
| Spondylolisthesis | 2 | 2022 | 160 | 0.910 |
Why?
|
| Orthopedic Procedures | 5 | 2023 | 1250 | 0.850 |
Why?
|
| Lumbosacral Region | 3 | 2018 | 289 | 0.830 |
Why?
|
| Periprosthetic Fractures | 2 | 2021 | 59 | 0.800 |
Why?
|
| Propensity Score | 9 | 2020 | 1848 | 0.750 |
Why?
|
| Reoperation | 9 | 2022 | 4215 | 0.710 |
Why?
|
| Scoliosis | 3 | 2023 | 713 | 0.700 |
Why?
|
| Radiculopathy | 1 | 2022 | 200 | 0.690 |
Why?
|
| Industry | 5 | 2022 | 362 | 0.670 |
Why?
|
| Inpatients | 5 | 2017 | 2512 | 0.670 |
Why?
|
| Hip Prosthesis | 3 | 2021 | 905 | 0.670 |
Why?
|
| Retrospective Studies | 43 | 2023 | 78293 | 0.620 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 261 | 0.570 |
Why?
|
| Sutures | 1 | 2019 | 291 | 0.570 |
Why?
|
| Telemedicine | 3 | 2023 | 2892 | 0.570 |
Why?
|
| Patient Discharge | 12 | 2022 | 3304 | 0.560 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 3669 | 0.540 |
Why?
|
| Knee Joint | 4 | 2020 | 1647 | 0.530 |
Why?
|
| Quality Improvement | 12 | 2020 | 3731 | 0.520 |
Why?
|
| Pain, Postoperative | 2 | 2022 | 1657 | 0.500 |
Why?
|
| Suture Techniques | 1 | 2019 | 786 | 0.470 |
Why?
|
| Hematoma | 1 | 2019 | 768 | 0.470 |
Why?
|
| Hip Joint | 1 | 2020 | 997 | 0.450 |
Why?
|
| Risk Factors | 26 | 2023 | 72413 | 0.430 |
Why?
|
| Colitis | 2 | 2018 | 1209 | 0.420 |
Why?
|
| Shoulder Joint | 1 | 2019 | 726 | 0.410 |
Why?
|
| Aged, 80 and over | 25 | 2022 | 57552 | 0.410 |
Why?
|
| Intraoperative Complications | 1 | 2019 | 1178 | 0.400 |
Why?
|
| Comorbidity | 9 | 2020 | 10348 | 0.380 |
Why?
|
| Aged | 38 | 2022 | 164222 | 0.380 |
Why?
|
| Blood Transfusion | 4 | 2020 | 1286 | 0.380 |
Why?
|
| Humans | 82 | 2023 | 746070 | 0.360 |
Why?
|
| Osteoarthritis, Knee | 1 | 2020 | 1215 | 0.350 |
Why?
|
| Treatment Outcome | 18 | 2023 | 63664 | 0.330 |
Why?
|
| Patient Satisfaction | 5 | 2023 | 3408 | 0.330 |
Why?
|
| Heart Arrest | 1 | 2019 | 1483 | 0.320 |
Why?
|
| Multivariate Analysis | 6 | 2020 | 12018 | 0.320 |
Why?
|
| Pediatrics | 2 | 2020 | 3559 | 0.300 |
Why?
|
| United States | 24 | 2023 | 70368 | 0.300 |
Why?
|
| Middle Aged | 33 | 2022 | 214419 | 0.280 |
Why?
|
| Fracture Fixation | 2 | 2020 | 358 | 0.280 |
Why?
|
| Male | 39 | 2022 | 351098 | 0.270 |
Why?
|
| Prosthesis-Related Infections | 2 | 2022 | 485 | 0.260 |
Why?
|
| Incidence | 8 | 2019 | 20812 | 0.250 |
Why?
|
| Female | 39 | 2023 | 382129 | 0.250 |
Why?
|
| Back Pain | 3 | 2022 | 538 | 0.230 |
Why?
|
| Physicians | 1 | 2022 | 4531 | 0.230 |
Why?
|
| Decompression | 1 | 2022 | 35 | 0.210 |
Why?
|
| Spinal Diseases | 2 | 2018 | 552 | 0.210 |
Why?
|
| Postoperative Period | 4 | 2019 | 1804 | 0.200 |
Why?
|
| Orthopedics | 2 | 2021 | 872 | 0.200 |
Why?
|
| Hospitalization | 2 | 2020 | 10327 | 0.190 |
Why?
|
| Adult | 24 | 2021 | 214969 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 7223 | 0.180 |
Why?
|
| Prescriptions | 1 | 2022 | 382 | 0.180 |
Why?
|
| Conflict of Interest | 2 | 2022 | 539 | 0.180 |
Why?
|
| Adolescent | 13 | 2020 | 86212 | 0.170 |
Why?
|
| Platelet Count | 2 | 2020 | 763 | 0.170 |
Why?
|
| Blood Urea Nitrogen | 1 | 2019 | 187 | 0.170 |
Why?
|
| Compensation and Redress | 1 | 2020 | 65 | 0.170 |
Why?
|
| Humerus | 1 | 2021 | 267 | 0.170 |
Why?
|
| Young Adult | 12 | 2020 | 57114 | 0.170 |
Why?
|
| Search Engine | 1 | 2020 | 138 | 0.170 |
Why?
|
| Prosthesis Failure | 2 | 2022 | 1204 | 0.170 |
Why?
|
| Prospective Payment System | 1 | 2020 | 135 | 0.160 |
Why?
|
| Thrombocytosis | 1 | 2019 | 82 | 0.160 |
Why?
|
| Sports Medicine | 1 | 2021 | 233 | 0.160 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 636 | 0.160 |
Why?
|
| Off-Label Use | 1 | 2020 | 177 | 0.160 |
Why?
|
| Spondylolysis | 1 | 2018 | 41 | 0.150 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 11655 | 0.150 |
Why?
|
| Perioperative Period | 1 | 2019 | 254 | 0.150 |
Why?
|
| Carboxylesterase | 1 | 2017 | 31 | 0.150 |
Why?
|
| Pneumonia | 2 | 2019 | 2110 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6453 | 0.140 |
Why?
|
| Sialic Acids | 1 | 2017 | 126 | 0.140 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2017 | 94 | 0.140 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 341 | 0.140 |
Why?
|
| Ankle | 1 | 2020 | 344 | 0.140 |
Why?
|
| Time Factors | 4 | 2019 | 39589 | 0.140 |
Why?
|
| Spironolactone | 1 | 2020 | 398 | 0.140 |
Why?
|
| Disclosure | 1 | 2022 | 731 | 0.140 |
Why?
|
| Prostatic Hyperplasia | 1 | 2020 | 526 | 0.140 |
Why?
|
| Low Back Pain | 2 | 2022 | 950 | 0.140 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 841 | 0.140 |
Why?
|
| Foot | 1 | 2020 | 557 | 0.130 |
Why?
|
| Cohort Studies | 7 | 2022 | 40505 | 0.130 |
Why?
|
| Fracture Fixation, Internal | 1 | 2021 | 943 | 0.120 |
Why?
|
| Age Factors | 4 | 2019 | 18145 | 0.120 |
Why?
|
| Sodium | 1 | 2019 | 1604 | 0.120 |
Why?
|
| Creatinine | 1 | 2019 | 1848 | 0.120 |
Why?
|
| Health Education | 1 | 2020 | 1045 | 0.110 |
Why?
|
| Intubation, Intratracheal | 2 | 2019 | 1355 | 0.110 |
Why?
|
| Operating Rooms | 1 | 2020 | 775 | 0.110 |
Why?
|
| Surgical Wound Infection | 2 | 2020 | 1488 | 0.110 |
Why?
|
| Data Mining | 1 | 2017 | 545 | 0.100 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 1569 | 0.100 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 801 | 0.100 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1080 | 0.100 |
Why?
|
| Pandemics | 2 | 2023 | 8434 | 0.100 |
Why?
|
| Internet | 2 | 2020 | 3038 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2019 | 998 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1750 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 1158 | 0.090 |
Why?
|
| Protein Transport | 1 | 2016 | 1962 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2017 | 1529 | 0.090 |
Why?
|
| Patient Admission | 1 | 2017 | 1358 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2018 | 1692 | 0.080 |
Why?
|
| Arthroplasty | 2 | 2022 | 307 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1952 | 0.080 |
Why?
|
| Data Collection | 1 | 2018 | 3287 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3136 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2018 | 23454 | 0.080 |
Why?
|
| Quinazolines | 1 | 2015 | 1350 | 0.080 |
Why?
|
| Venous Thromboembolism | 2 | 2018 | 1771 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2572 | 0.080 |
Why?
|
| Risk | 1 | 2020 | 9521 | 0.070 |
Why?
|
| Preoperative Period | 2 | 2019 | 548 | 0.070 |
Why?
|
| Hospitals | 1 | 2020 | 3852 | 0.070 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 1988 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2020 | 12633 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4192 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3658 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5765 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 15539 | 0.050 |
Why?
|
| Glycosylation | 2 | 2017 | 1077 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3054 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3166 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3331 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2016 | 5609 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9172 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 5261 | 0.050 |
Why?
|
| Smoking | 1 | 2018 | 8975 | 0.050 |
Why?
|
| Injections, Intra-Articular | 1 | 2022 | 276 | 0.050 |
Why?
|
| Hypertension | 1 | 2020 | 8359 | 0.040 |
Why?
|
| Accounting | 1 | 2020 | 25 | 0.040 |
Why?
|
| Stroke | 1 | 2022 | 9692 | 0.040 |
Why?
|
| Computers | 1 | 2022 | 590 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2022 | 785 | 0.040 |
Why?
|
| Rotator Cuff | 1 | 2021 | 335 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 773 | 0.040 |
Why?
|
| Acetabulum | 1 | 2021 | 530 | 0.040 |
Why?
|
| Hexosamines | 1 | 2017 | 42 | 0.040 |
Why?
|
| Butyric Acid | 1 | 2017 | 51 | 0.040 |
Why?
|
| Acetylgalactosamine | 1 | 2017 | 38 | 0.040 |
Why?
|
| Muscles | 1 | 2022 | 1584 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2022 | 591 | 0.040 |
Why?
|
| Ownership | 1 | 2019 | 331 | 0.040 |
Why?
|
| Reading | 1 | 2020 | 551 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 414 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 12670 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11539 | 0.030 |
Why?
|
| Alopecia | 1 | 2020 | 412 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2017 | 187 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 16652 | 0.030 |
Why?
|
| Femur | 1 | 2021 | 1287 | 0.030 |
Why?
|
| Comprehension | 1 | 2020 | 606 | 0.030 |
Why?
|
| Cricetulus | 1 | 2017 | 817 | 0.030 |
Why?
|
| Child | 2 | 2020 | 78469 | 0.030 |
Why?
|
| HIV Infections | 1 | 2021 | 16937 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 451 | 0.030 |
Why?
|
| CHO Cells | 1 | 2017 | 1393 | 0.030 |
Why?
|
| STAT Transcription Factors | 1 | 2015 | 184 | 0.030 |
Why?
|
| Aftercare | 1 | 2019 | 892 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1867 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 11941 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20754 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2018 | 959 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 869 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 3011 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2017 | 715 | 0.030 |
Why?
|
| Endocytosis | 1 | 2016 | 979 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2019 | 1318 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 965 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 35781 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 1732 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2018 | 1804 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2015 | 1731 | 0.020 |
Why?
|
| Heparin | 1 | 2017 | 1631 | 0.020 |
Why?
|
| ROC Curve | 1 | 2017 | 3496 | 0.020 |
Why?
|
| Anemia | 1 | 2019 | 1481 | 0.020 |
Why?
|
| Binding Sites | 1 | 2017 | 6025 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 2136 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2019 | 9596 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12272 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 10095 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9280 | 0.020 |
Why?
|
| Sex Factors | 1 | 2018 | 10278 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2018 | 5215 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2019 | 3326 | 0.010 |
Why?
|
| Sepsis | 1 | 2018 | 2589 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2015 | 8298 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8170 | 0.010 |
Why?
|
| Medicare | 1 | 2021 | 6541 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9114 | 0.010 |
Why?
|
| Insulin | 1 | 2017 | 6470 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25174 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 12985 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 15306 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 5164 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10303 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29072 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13531 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 166308 | 0.000 |
Why?
|